# Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque

> **NCT00760786** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Intensive lipid lowering plus Omega3-fatty acid
- **DRUG:** Moderate lipid lowering plus Omega3-fatty acid
- **DRUG:** Intensive lipid lowering plus placebo
- **DRUG:** Moderate lipid lowering plus placebo

## Key facts

- **NCT ID:** NCT00760786
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2010-02
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760786, "Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00760786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*